School of Veterinary Medicine, Federal University of Uberlandia, Uberlândia, Brazil.
Institute of Biotechnology, Federal University of Uberlandia, Uberlândia, Brazil.
Front Cell Infect Microbiol. 2021 Jan 8;10:571040. doi: 10.3389/fcimb.2020.571040. eCollection 2020.
(CJ) is the most prevalent zoonotic pathogen of chicken meat and related products, which may lead to gastroenteritis and autoimmune diseases in humans. Although controlling this bacterium is important, CJ strains resistance against traditional antibiotic therapy has been increased. Vegetable oils and fats are natural biomaterials explored since the Ancient times, due to their therapeutic properties. Nanotechnology has promoted the miniaturization of materials, improving bioavailability and efficacy, while reducing the toxicity of loaded active molecules. In this work, a screening of 28 vegetable oils was firstly performed, in order to select anti-CJ candidates by the disc diffusion test. Thus, the selected liquid lipids were used as active molecules in nanostructured lipid carriers (NLC) formulations. The three resultant systems were characterized in terms of particle size (200 nm), polydispersity index (0.15), and zeta potential (~-35mV), and its physicochemical stability was confirmed for a year, at 25°C. The structural properties of NLC were assessed by infrared (FTIR-ATR) and differential scanning calorimetry (DSC) analyses. The spherical nanoparticle morphology and narrow size distribution was observed by transmission electron microscopy (TEM) and field emission scanning electron (FE-SEM) analyses, respectively. Then, the antimicrobial activity test determined the minimum inhibitory concentration (MIC) of each formulation against CJ strains, in both free (1-3 mg/ml) and sessile (0.78 mg/ml) forms. Finally, the biocompatibility of NLC was demonstrated through cell viability using VERO cell line, in which F6 was found twice less cytotoxic than pure olibanum oil. Considering the abovementioned achieved, F6 formulation is able to be evaluated in the anti-CJ efficacy assays.
(CJ) 是鸡肉和相关产品中最常见的动物源性病原体,可导致人类肠胃炎和自身免疫性疾病。尽管控制这种细菌很重要,但 CJ 菌株对传统抗生素治疗的耐药性已经增加。植物油和脂肪是自古以来探索的天然生物材料,由于其治疗特性。纳米技术促进了材料的小型化,提高了生物利用度和疗效,同时降低了负载活性分子的毒性。在这项工作中,首先对 28 种植物油进行了筛选,以便通过圆盘扩散试验选择抗 CJ 候选物。因此,所选的液体脂质被用作纳米结构脂质载体 (NLC) 制剂中的活性分子。从粒径(200nm)、多分散指数(0.15)和 Zeta 电位(~-35mV)方面对这三个所得系统进行了表征,并在 25°C 下确认了其物理化学稳定性为一年。通过红外(FTIR-ATR)和差示扫描量热法(DSC)分析评估了 NLC 的结构特性。通过透射电子显微镜(TEM)和场发射扫描电子显微镜(FE-SEM)分析分别观察到球形纳米颗粒形态和窄的粒径分布。然后,通过抗菌活性试验确定了每种制剂对 CJ 菌株的最小抑菌浓度(MIC),无论是游离(1-3mg/ml)还是固定(0.78mg/ml)形式。最后,通过使用 VERO 细胞系测定细胞活力来证明 NLC 的生物相容性,其中 F6 被发现比纯乳香油的细胞毒性低两倍。考虑到上述结果,F6 制剂能够在抗 CJ 功效试验中进行评估。